Brief: Tenaya Therapeutics Q1 Net Income USD -32.228 Million Vs. IBES Estimate USD -33.4 Million
14/05/2024 21:05
May 14 (Reuters) - Tenaya Therapeutics Q1 operating expenses USD 33.762 million. * Q1 pretax profit USD -32.228 million vs. IBES estimate USD -33.4 million * Q1 operating income USD -33.762 million * Q1 basic EPS USD -0.4
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027